Post hoc comparisons revealed significantly higher MMP-10 levels in AD dementia patients (mean = 28.4 pg/mL) and MCI-AD patients (24.0 pg/mL) compared to CU A− (16.5 pg/mL, P < 0.01) and CU A+ controls (15.4 pg/mL, P < 0.01). Here, MMP10 is linked to Alzheimer disease.